Skip to Content

News

Bolsonaro responde pregunta sobre las muertes por covid-19 en Brasil diciendo que no quiere que lo “molesten”

Melissa Velásquez Loaiza (CNN) — El presidente de Brasil, Jair Bolsonaro, dijo que no quiere que lo “molesten” cuando se le preguntó sobre el número de muertos por covid-19 en Brasil este lunes. En un video publicado en su página de YouTube, Bolsonaro estaba hablando con la prensa y simpatizantes durante una visita a Guarujá

Continue Reading

IMF foresees a slight drop in global growth from pandemic

By MARTIN CRUTSINGER AP Economics Writer WASHINGTON (AP) — The International Monetary Fund is slightly downgrading its outlook for the global recovery from the pandemic recession, reflecting the persistence of supply chain disruptions in industrialized countries and deadly disparities in vaccination rates between rich and poor nations. In its latest World Economic Outlook, the IMF

Continue Reading

IMF foresees a slight drop in global growth from pandemic

By MARTIN CRUTSINGER AP Economics Writer WASHINGTON (AP) — The International Monetary Fund is slightly downgrading its outlook for the global recovery from the pandemic recession, reflecting the persistence of supply chain disruptions in industrialized countries and deadly disparities in vaccination rates between rich and poor nations. In its latest World Economic Outlook, the IMF

Continue Reading

Acusan al presidente de Brasil, Jair Bolsonaro, de “crímenes contra la humanidad” ante la Corte Penal Internacional

Juan Pablo Elverdin (CNN) — Un grupo de abogados climáticos ha instado a la Corte Penal Internacional (CPI) a que investigue al presidente de Brasil, Jair Bolsonaro, por sus supuestos ataques a la Amazonía, que según ellos equivalen a “crímenes contra la humanidad”. La organización austriaca sin ánimo de lucro AllRi presentó este martes una

Continue Reading

‘Dopesick’ gives Purdue Pharma and OxyContin a sweeping dramatic treatment

Review by Brian Lowry, CNN “Dopesick” is a major undertaking, exploring the opioid crisis from multiple angles, including the ground-level carnage inflicted by OxyContin addiction, Purdue Pharma’s inner workings and the government personnel seeking to combat it. Scattered in places, in its totality it’s an engrossing eight-part series, made more so by Purdue’s bankruptcy proceedings

Continue Reading